Login / Signup

A Practical Guide to Using Biologics in Pediatric Dermatology.

Annie GeorgeRafael Paolo LansangPerla LansangMelinda J Gooderham
Published in: Journal of cutaneous medicine and surgery (2024)
Psoriasis, hidradenitis suppurativa (HS), atopic dermatitis (AD), and chronic spontaneous urticaria (CSU), are common, immune-mediated, chronic, inflammatory skin diseases that can affect the pediatric population. While there is adequate evidence supporting the use of biologics in pediatric patients, concerns regarding safety and efficacy amongst healthcare providers are not uncommon. However, new emerging evidence in this population highlights the safety of biologic therapy, making it crucial to review and establish a practical guide for their use. This article describes a methodological framework for initiating biologics in the management of pediatric psoriasis, HS, AD, and CSU, with a special focus on baseline work-up, monitoring, dosing, and considerations in this population.
Keyphrases
  • atopic dermatitis
  • hidradenitis suppurativa
  • healthcare
  • rheumatoid arthritis
  • stem cells
  • soft tissue
  • drug induced
  • health information
  • childhood cancer